Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (59)
  • 2024 (74)
  • 2023 (77)
  • 2022 (110)
  • 2021 (102)
  • 2020 (19)
  • 2019 (15)
  • 2018 (5)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4010)
  • Synthetic drugs (1064)
  • Guns/Weapons (989)
  • OCDETF/Task Force (810)
  • Fake Pills (654)
  • Arrests/Convictions - Major (603)
  • Guilty Plea (529)
  • Seizures (Drugs/Property) (456)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (267)
  • Take Back Day (246)
  • Diversion Division (242)
  • Task Forces/Task Force Officers (230)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Other (8)
  • Campaigns (7)
  • Critical Incident (6)
  • Counterfeit Pills (5)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Extraditions (50)

Drug Name

  • Fentanyl (89)
  • Cocaine (86)
  • Methamphetamine (63)
  • Oxycodone (48)
  • Opioids (45)
  • Heroin (38)
  • Marijuana (Cannabis) (16)
  • Synthetic Opioids (15)
  • Hydromorphone (12)
  • Benzodiazepines (7)
  • Morphine (7)
  • Ketamine (4)
  • Ecstasy/MDMA (3)
  • Methadone (3)
  • Steroids (3)
  • Amphetamines (2)
  • Marijuana Concentrates (2)
  • GHB (1)
  • K2/Spice (1)
  • Psilocybin (1)

Field Division

  • St. Louis (63)
  • Washington, DC (54)
  • New York (35)
  • New England (34)
  • Miami (33)
  • Chicago (30)
  • Houston (26)
  • Atlanta (21)
  • New Jersey (21)
  • San Francisco (20)
  • Seattle (19)
  • Sede (19)
  • San Diego (17)
  • Dallas (16)
  • El Paso (16)
  • Phoenix (9)
  • Louisville (8)
  • Los Angeles (6)
  • New Orleans (5)
  • Rocky Mountain (5)
  • Detroit (3)
  • Omaha (2)
  • Philadelphia (1)
Clear All Results
PRESS RELEASE

Southern New Mexico Medical Spa Operator Settles Allegations of Controlled-Substance Recordkeeping Violations

Diciembre 03, 2025
Note: View the Settlement Agreement ALBUQUERQUE – The United States has reached a civil settlement with Luis Carlos Cordova, operator of Limitless Aesthetics and Healthcare in Santa Teresa, New Mexico, to resolve allegations that he failed to meet federal controlled-substance recordkeeping requirements under the Controlled Substances Act. According to the...
Diciembre 03, 2025
PRESS RELEASE

Drug Distribution Takedowns in Seattle Area Result in 18 Arrests and More Than 3.4 Million Lethal Doses of Fentanyl Seized

Noviembre 20, 2025
SEATTLE – Two long-term investigations in the Western District of Washington wrapped up in October 2025 with multiple arrests and significant seizures of narcotics and firearms, announced U.S. Attorney Charles Neil Floyd. This afternoon, Jose Isabel Sandoval Zuniga, 30, of Sammamish, Washington who served as a primary source of firearms...
Noviembre 20, 2025
PRESS RELEASE

Digital Health Company Cofounder/CEO and Clinical President Convicted in $100M Adderall Distribution and Health Care Fraud Scheme

Noviembre 20, 2025
SAN FRANCISCO – United States Drug Enforcement Administration (“DEA”) San Francisco Division Special Agent in Charge Bob Beris, DEA New York Division Special Agent in Charge Frank Tarentino, along with our law enforcement partners Homeland Security Investigations (“HSI”) , U.S. Department of Health and Human Services – Office of Inspector...
Noviembre 20, 2025
PRESS RELEASE

Digital Health Company Cofounder/CEO and Clinical President Convicted in $100M Adderall Distribution and Health Care Fraud Scheme

Noviembre 19, 2025
NEW YORK – United States Drug Enforcement Administration (“DEA”) New York Division Special Agent in Charge Frank Tarentino, DEA San Francisco Division Special Agent in Charge Robert Beris, along with our law enforcement partners Homeland Security Investigations (“HSI”) New York , U.S. Department of Health and Human Services – Office...
Noviembre 19, 2025
PRESS RELEASE

Sinaloa Cartel Senior Lieutenant Pleads Guilty

Noviembre 19, 2025
Phoenix, Ariz. – Jose Guadalupe Tapia-Quintero, 54, of San Francisco de Tacuichamona, Sinaloa, Mexico pleaded guilty on November 17, 2025 for Conspiracy to Distribute Methamphetamine with Intent to Import into the United States and Conspiracy to Commit Concealment Money Laundering. Sentencing is scheduled for February 2, 2026, before United States...
Noviembre 19, 2025
PRESS RELEASE

Alleged Sinaloa Cartel Methamphetamine Trafficker Extradited from Mexico

Noviembre 18, 2025
SAN DIEGO – Marco Antonio Lopez-Guerrero, an alleged Mexicali-based methamphetamine trafficker linked to the Sinaloa Cartel, was extradited from Mexico on October 24th to face drug and firearms charges. Lopez-Guerrero was indicted by a federal grand jury in the Southern District of California in July 2020. He is charged with...
Noviembre 18, 2025
PRESS RELEASE

DEA Hosts the 29th National Prescription Drug Take Back Day on Saturday, October 25th

Octubre 22, 2025
SAN FRANCISCO – The Drug Enforcement Administration, in collaboration with nearly 4,000 law enforcement partners across the country, will host the 29th National Prescription Drug Take Back Day this Saturday, October 25, from 10 a.m. to 2 p.m. At nearly 4,000 collection sites throughout the United States, DEA’s National Prescription...
Octubre 22, 2025
PRESS RELEASE

Honduran Nationals Extradited to the United States to Face Federal Fentanyl Trafficking Charges

Septiembre 17, 2025
PORTLAND, Ore.— Two Honduran nationals were extradited from Honduras to the United States to face charges for their roles in conspiring to distribute fentanyl in Oregon. Teodoro Rodas Dubon, 32, and Erick Yojan Lopez Miralda, 38, made their initial appearances in federal court in Portland Tuesday. According to court documents...
Septiembre 17, 2025
PRESS RELEASE

Clay County Pharmacy Investigation and Prosecution Ends in Guilty Pleas

Septiembre 11, 2025
NASHVILLE – Thomas K. Weir, 65, majority owner of Oakley Pharmacy d/b/a Dale Hollow Pharmacy and Clay County Xpress Pharmacy (“Xpress Pharmacy”); William L. Donaldson, 65, former owner and pharmacist of Dale Hollow Pharmacy (then known as Donaldson Pharmacy); and Pamela Spivey, 55, co-owner of Xpress Pharmacy (all of Celina...
Septiembre 11, 2025
PRESS RELEASE

Drug Trafficker Unlawfully Residing in the United States Sentenced to Federal Prison for His Leading Role in Distributing Fentanyl and Heroin and Laundering Millions in Drug Proceeds

Septiembre 05, 2025
PORTLAND, Ore.— Luis Antonio Beltran Arredondo, 35, a Mexican National residing in Las Vegas, was sentenced today to 135 months in federal prison and five years of supervised release for conspiring to distribute fentanyl and heroin in Oregon, and for conspiring to launder drug proceeds through a Tualatin Beauty Salon...
Septiembre 05, 2025
Showing 1 - 10 of 464 results

Paginación

  • Current page 1
  • Página 2
  • Página 3
  • Página 4
  • Página 5
  • Página 6
  • Página 7
  • Página 8
  • Página 9
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster